Disruptive Dose with Jayne Krahn

SVP Product and Research Operations, M3 MI

In this DHCG Disruptive Dose, Mark Bard speaks with Jayne Krahn, SVP Product and Research Operations at M3 MI, about new 2026 Consumer Health Study findings. Krahn explains that the 122 million consumers using AI for health information aren’t replacing doctors but using AI as a pre- and post-visit layer, and that winning placement in AI summaries now requires clear, structured, up-to-date content. She notes that nearly 40% of patients face real access barriers like cost and transportation, and that GLP-1 interest has jumped 20% year-over-year even as cost, side-effect fears, and low DTP platform awareness still block conversion. Her key takeaway: patient behavior has outpaced most marketing strategies, and brands must now focus on helping patients take action, not just reaching them.